|
Catenacci, Daniel V T; Junttila, Melissa R; Karrison, Theodore et al. (2015) Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer. J Clin Oncol 33:4284-92
|
|
Taylor, Rodney J; Saloura, Vassiliki; Jain, Ajay et al. (2015) Ex vivo antibody-dependent cellular cytotoxicity inducibility predicts efficacy of cetuximab. Cancer Immunol Res 3:567-74
|
|
Jain, Nitin; Curran, Emily; Iyengar, Neil M et al. (2014) Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial. Clin Cancer Res 20:490-8
|
|
Gangadhar, Tara C; Clark, Joseph I; Karrison, Theodore et al. (2013) Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma. Invest New Drugs 31:769-73
|
|
Churpek, Jane E; Pro, Barbara; van Besien, Koen et al. (2013) A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomas. Cancer 119:1683-9
|
|
de Souza, Jonas A; Davis, Darren W; Zhang, Yujian et al. (2012) A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 18:2336-43
|
|
Sharma, Manish R; Wroblewski, Kristen; Polite, Blase N et al. (2012) Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium. Invest New Drugs 30:1211-5
|
|
Kindler, Hedy Lee; Wroblewski, Kristen; Wallace, James A et al. (2012) Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium. Invest New Drugs 30:382-6
|
|
O'Donnell, Peter H; Stadler, Walter M (2012) Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II? Clin Cancer Res 18:2809-16
|
|
Ward, J E; Karrison, T; Chatta, G et al. (2012) A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study. Prostate Cancer Prostatic Dis 15:87-92
|
Showing the most recent 10 out of 20 publications
